Sun Pharmaceuticals Industries can complete its $4 billion purchase of Ranbaxy Laboratories if it sells Ranbaxy’s interests in generic minocycline tablets to Torrent Pharmaceuticals Ltd., according to the Federal Trade Commission....
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information: